<DOC>
	<DOCNO>NCT00824369</DOCNO>
	<brief_summary>The purpose protocol ass long-term safety tolerability subject discontinue reason UK-453,061 qualifying study .</brief_summary>
	<brief_title>A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1</brief_title>
	<detailed_description>To assess long term safety tolerability subject discontinue reason UK-453,061 study . The study also assess efficacy subsequent regimen patient . The trial terminate prematurely January 29 , 2013 , due decision sponsor discontinue development lersivirine . The decision terminate trial base safety efficacy concern .</detailed_description>
	<criteria>Previous participation qualify study . Male female least 18 year age available followup period least 96 week . Concurrent treatment another clinical trial . Unwilling unable follow 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Rollover</keyword>
	<keyword>Safety .</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>treatment experience</keyword>
</DOC>